M. D. Roberto Illa / MDRoberto Illa
Librería Samer Atenea
Librería Aciertas (Toledo)
Kálamo Books
Librería Perelló (Valencia)
Librería Elías (Asturias)
Donde los libros
Librería Kolima (Madrid)
Librería Proteo (Málaga)
The Illa Protocol answers the key questions about diabetes treatment which are not addressed by currently accepted dogma. The published failures of American Diabetes Association guidelines to halt or reverse disease progression has left medical practitioners confused and frustrated. This book outlines a new approach to diabetes which results in much better patient outcomes. Old concepts which have resulted in years of increased morbidity and mortality are exposed and replaced with practical principles which lead to success. Illustrative original case reports are presented which demonstrate that, not only diabetes, but chronic kidney disease in the diabetic can be reversed at all stages in most patients. The fundamental questions of what constitutes Type 1 vs. Type 2 diabetes is discussed in terms of recent published reports and the author’s case experience. The initial series of laboratory tests which are needed to properly classify the diabetic and select the most effective therapy are outlined. Diabetes cannot defined simply by elevation of blood sugar as stated by the American Diabetes Association. Patients with hyperinsulinemic hypoglycemia (nesidioblastosis) can have elevated blood sugars which fit the official and prevailing definition of diabetes mellitus. However, they are the opposite of diabetics. Their pancreatic beta cells produce too much insulin. Diabetics have impaired insulin production or release from their beta cells. A method of treatment of the diabetic with chronic kidney disease and ESRD is provided in this book that involves the use of oral medications. Using the method of blood sugar control outlined and the medications suggested for the reversal of renal insufficiency, the vast majority of diabetic patients can be saved from the tragic and expensive outcome of kidney dialysis. The doctor should match your patient’s kidney function to the right insulin or oral product.
